evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract,articles/19/pmid,articles/19/title,articles/19/journal,articles/19/pubDate,articles/19/volume,articles/19/issue,articles/19/pages,articles/19/authors,articles/19/elocationId,articles/19/link,articles/19/reference,articles/19/abstract,articles/20/pmid,articles/20/title,articles/20/journal,articles/20/pubDate,articles/20/volume,articles/20/issue,articles/20/pages,articles/20/authors,articles/20/elocationId,articles/20/link,articles/20/reference,articles/20/abstract,articles/21/pmid,articles/21/title,articles/21/journal,articles/21/pubDate,articles/21/volume,articles/21/issue,articles/21/pages,articles/21/authors,articles/21/elocationId,articles/21/link,articles/21/reference,articles/21/abstract
16965,GENE_BACKGROUND,,"The ERBB4 gene encodes a transmembrane tyrosine kinase in the ERBB family of receptors that plays a critical role in the development of the nervous system, lung, heart and mammary glands (PMID: 14504474, 9208852, 22427524, 25492965). Binding of its ligands, the neuregulins (NRG1-4), betacellulin (BTC), HB-EGF or epiregulin (EPR), is required for ERBB4 to form kinase active dimers with other ERBB isoforms, preferentially ERBB2. In turn, this initiates downstream signaling via the oncogenic PI3-kinase/AKT, RAS/MAP-kinase, SRC and STAT signaling cascades, among others (PMID: 9130710, 10220407,19208461, 11252954). Mutations distributed throughout the entire ERBB4 gene have been identified at moderate to low frequencies (<20%) with no veritable hotspots in a variety of tissue types, including melanoma (PMID: 22817889, 22842228, 19718025, 24755198), lung (PMID: 18948947), gastric (PMID: 25079317, 25583476) and colorectal cancers (PMID: 22895193). Evidence in breast cancer cell lines highlights a novel role for ERBB4 in mediating acquired resistance to ERBB2 inhibitors (PMID: 25590338). Conversely, a subset of literature points to a growth-suppressive role for ERBB4 in breast cancer (PMID: 17120616, 24791013, 16832345, 20603612). The prognostic value of ERBB4 expression in cancer is still debatable, as reports have documented both better and worse outcomes in these tumors; however, this may be due to the lack of discrimination between ERBB4 variants (PMID: 25492965, 18454307).",,2017-04-03,,2066,ERBB4,erb-b2 receptor tyrosine kinase 4,True,ENST00000342788,NM_005235.2,ALS19,p180erbB4,HER4,False,25079317,Comprehensive molecular characterization of gastric adenocarcinoma.,Nature,2018-09-11T20:14:00,513,7517,202-9,Cancer Genome Atlas Research Network.,doi: 10.1038/nature13480,,0001-09-11,,10220407,0001-05-01,Proceedings of the National Academy of Sciences of the United States of America,0001-04-27,96,9,4995-5000,Klapper LN et al,,,0001-04-27,,22895193,Recurrent R-spondin fusions in colon cancer.,Nature,2018-08-30T20:12:00,488,7413,660-4,Seshagiri S et al,doi: 10.1038/nature11282,,0001-08-30,,9130710,"ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.",The EMBO journal,0001-04-01,16,7,1647-55,Graus-Porta D et al,,,0001-04-01,,19718025,Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.,Nature genetics,2018-10-01T20:09:00,41,10,1127-32,Prickett TD et al,doi: 10.1038/ng.438,,0001-10-01,,20603612,Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells.,Oncogene,2018-09-16T20:10:00,29,37,5214-9,Das PM et al,doi: 10.1038/onc.2010.271,,0001-09-16,,18454307,Role of ErbB4 in breast cancer.,Journal of mammary gland biology and neoplasia,2018-06-01T20:08:00,13,2,259-68,Sundvall M et al,doi: 10.1007/s10911-008-9079-3,,0001-06-01,,25492965,Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.,Science signaling,2017-12-09T20:14:00,7,355,ra116,Haskins JW et al,doi: 10.1126/scisignal.2005770,,2017-12-09T03:55:00,,25583476,Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.,Proceedings of the National Academy of Sciences of the United States of America,2018-01-27T20:15:00,112,4,1107-12,Chen K et al,doi: 10.1073/pnas.1422640112,,0001-01-27,,14504474,ErbB4 signaling during breast and neural development: novel genetic models reveal unique ErbB4 activities.,"Cell cycle (Georgetown, Tex.)",2018-11-01T20:03:00,2,6,555-9,Jones FE et al,,,0001-11-01,,22427524,The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.,American journal of physiology. Heart and circulatory physiology,2018-06-01T20:12:00,302,11,H2139-47,Wadugu B et al,doi: 10.1152/ajpheart.00063.2012,,0001-06-01,,9208852,Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis.,Neuron,0001-06-01,18,6,847-55,Burden S et al,,,0001-06-01,,22817889,A landscape of driver mutations in melanoma.,Cell,2018-07-20T20:12:00,150,2,251-63,Hodis E et al,doi: 10.1016/j.cell.2012.06.024,,0001-07-20,,19208461,ErbB receptors and signaling pathways in cancer.,Current opinion in cell biology,2018-04-01T20:09:00,21,2,177-84,Hynes NE et al,doi: 10.1016/j.ceb.2008.12.010,,0001-04-01,,11252954,Untangling the ErbB signalling network.,Nature reviews. Molecular cell biology,2018-02-01T20:01:00,2,2,127-37,Yarden Y et al,,,0001-02-01,,22842228,Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.,Nature genetics,2018-09-01T20:12:00,44,9,1006-14,Krauthammer M et al,doi: 10.1038/ng.2359,,0001-09-01,,17120616,Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.,Oncology research,2006,16,4,179-93,Pitfield SE et al,,,Pitfield SE et al. Oncology research. 2006;16(4)179-93.,,16832345,A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities.,Oncogene,2018-01-18T20:07:00,26,3,462-6,Vidal GA et al,,,0001-01-18,,24791013,Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.,Journal of cancer research and therapeutic oncology,2018-08-22T20:13:00,True,True,10,Gallo RM et al,,,0001-08-22,,18948947,Somatic mutations affect key pathways in lung adenocarcinoma.,Nature,2018-10-23T20:08:00,455,7216,1069-75,Ding L et al,doi: 10.1038/nature07423,,0001-10-23,,25590338,Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.,"Cell cycle (Georgetown, Tex.)",2015,14,4,648-55,Canfield K et al,doi: 10.4161/15384101.2014.994966,,"Canfield K et al. Cell cycle (Georgetown, Tex.). 2015;14(4)648-55.",,24755198,A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.,Molecular cancer therapeutics,2018-07-01T20:14:00,13,7,1918-28,Xia J et al,doi: 10.1158/1535-7163.MCT-13-0804,,0001-07-01,
16964,GENE_SUMMARY,,"ERBB4, a receptor tyrosine kinase, is mutated at low to moderate frequencies in various cancers, most frequently in melanoma and lung cancer.",,2017-04-03,,2066,ERBB4,erb-b2 receptor tyrosine kinase 4,True,ENST00000342788,NM_005235.2,ALS19,p180erbB4,HER4,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
